Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

Global Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Trends & Analysis - Forecasts to 2027 By Animal Type (Companion Animal and Livestock), By Application Scope (Osteoarthritis and Joint Pain, Postoperative Pain, and Others), By End-Use (Hospitals and Clinics, Retail Outlet, and Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size

The Global Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market is projected to grow at a CAGR value of 7.5% from 2022 to 2027. The growing demand for veterinary services, increased focus on companion animal health, growing pet adoptions, and stringent regulations on pet ownership have increased the demand for non-steroidal anti-inflammatory drugs from the companion animals segment.

Human society as a whole has been dependent on livestock for food, manual labor, and companionship since the dawn of civilization. The growing human population has increased the demand for livestock. Increasing instances of disease outbreaks among livestock have increased the demand for non-steroidal anti-inflammatory drugs. Injuries to livestock, the growing need for corrective surgery, and other concerns have increased the demand for animal-grade painkillers. The advantages of non-steroidal anti-inflammatory drugs such as long-term effectiveness, lack of influence on animal behaviour, and their availability in various forms such as oral, injectable, and liquid forms have led to their widespread adoption of non-steroidal anti-inflammatory drugs.

The growing availability of veterinary services, increasing investment in veterinary hospitals, growing livestock safety regulations are expected to increase the demand for non-steroidal anti-inflammatory drugs.

The growing number of viral disease outbreaks among livestock, growing awareness of companion animal health, and increased willingness to spend on companion animal health procedures are expected to contribute positively to the growth of the non-steroidal anti-inflammatory drugs market.

The market’s growth is restrained by the availability of alternate medicines, higher cost of these medicines, lack of veterinary services in developing regions, and stringent regulations.

The COVID-19 pandemic has caused various issues restraining the growth of the non-steroidal anti-inflammatory drugs market. The increased focus on animal health owing to the pandemic has been positive for the market. While restrictions and lockdowns have seen pet owners postpone surgeries and other procedures which have decreased the demand for non-steroidal anti-inflammatory drugs. The market is expected to bounce back to pre-pandemic growth rates as postponed surgeries and procedures were carried out.

global veterinary non-steroidal anti-inflammatory drugs (nsaids) market

Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: By Animal Type

Based on the animal type, the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market is segmented into companion animal and livestock segments. The companion animal segment is expected to hold the largest piece of the market during the forecast period. As pet owners tend to be more emotionally invested in the health of their pets, they’re more willing to take up expensive surgeries to cure their companions. The ability of non-steroidal anti-inflammatory drugs to not cause any behavioural modifications in animals has led to the increased adoption of non-steroidal anti-inflammatory drugs among companion animals.

Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: By Application

Based on the various avenues of application of veterinary non-steroidal anti-inflammatory drugs (NSAIDs), the market is segmented into osteoarthritis and joint pain, postoperative pain, and others. The postoperative pain segment held the lion’s share of the market. The growing number of surgeries being carried out on companion animals and livestock management surgeries to improve the quality of life of animals have led to the dominance of the postoperative pain segment.

The osteoarthritis and joint pain segment is expected to become the fastest-growing segment during the forecast period. Increased spending on animal healthcare, growing regulations on pet healthcare, and increased willingness to spend on pet healthcare have led to an increase in animal life expectancy. The increase in animal life expectancy is expected to increase the instances of arthritis among animals which is expected to increase the demand for non-steroidal anti-inflammatory drugs for treating arthritis and joint pain. The lack of behavioural modification through the use of non-steroidal anti-inflammatory drugs is another factor that is expected to drive the osteoarthritis and joint pain segment.

Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: By End-Use

Based on the various end-use, the market is segmented into hospitals and clinics, retail outlets, and others. The hospitals and clinics segment held the lion’s share of the market. The growing investment in veterinary healthcare infrastructure, growing demand for animal surgeries, and increased usage of non-steroidal anti-inflammatory drugs in veterinary hospitals and clinics. The growing application of non-steroidal anti-inflammatory drugs for treating arthritis and joint pains among animals has resulted in the retail stores registering the fastest growth rates.

asia pacific veterinary non-steroidal anti-inflammatory drugs (nsaids) market

Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: By Region

Based on region, the market can be segmented into various regions such as North America, Europe, Central and South America, Middle East and North Africa, and Asia Pacific regions.

The North American region is expected to be the dominant force in the market during the forecast period. The region’s increased spending on animal healthcare, growing pet healthcare expenditure, excellent veterinary infrastructure, and stringent regulations on animal healthcare and quality of life have led to the dominance of the region.

The APAC region is envisaged to log significantly greater growth rates than the other regions during the forecast period. The growing demand for companion animals, increasingly stringent regulations, large livestock population in the region, and the growing availability of pet healthcare are expected to be the major drivers of the APAC region.

Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share and Competitor Analysis

Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Zoetis Inc., Merck and Co Inc., and Assisi Animal Health, among others, are the key players in the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Digital Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Overview, 2021-2027

2.1.1 Industry Overview

2.1.2 Animal Type Overview

2.1.3 Application Overview

2.1.4 End-Use Overview

2.1.6 Regional Overview

Chapter 3 Digital Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2021-2027

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rising demand for companion animal surgeries

3.3.2 Industry Challenges

3.3.2.1 Availability of alternated medicine and high cost of veterinary non-steroidal anti-inflammatory drugs (NSAIDs)

3.4 Prospective Growth Scenario

3.4.1 Animal Type Growth Scenario

3.4.2 Application Growth Scenario

3.4.3 End-Use Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 End-Use Overview

3.11 Market Share Analysis, 2021

3.11.1 Company Positioning Overview, 2021

Chapter 4 Digital Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Animal Type

4.1 Animal Type Outlook

4.2 Companion Animal

4.2.1 Market Size, By Region, 2021-2027 (USD Billion)

4.3 Livestock

4.3.1 Market Size, By Region, 2021-2027 (USD Billion)

Chapter 5 Digital Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Application

5.1 Application Outlook

5.2 Osteoarthritis and Joint Pain

5.2.1 Market Size, By Region, 2021-2027 (USD Billion)

5.3 Postoperative Pain

5.3.1 Market Size, By Region, 2021-2027 (USD Billion)

5.4 Others

5.4.1 Market Size, By Region, 2021-2027 (USD Billion)

Chapter 6 Digital Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By End-Use

6.1 Hospitals and Clinics

6.1.1 Market Size, By Region, 2021-2027 (USD Billion)

6.2 Retail Outlet

6.2.1 Market Size, By Region, 2021-2027 (USD Billion)

6.3 Others

6.3.1 Market Size, By Region, 2021-2027 (USD Billion)

Chapter 7 Digital Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Region

7.1 Regional outlook

7.2 North America

7.2.1 Market Size, By Country 2021-2027 (USD Billion)

7.2.2 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.2.3 Market Size, By Application, 2021-2027 (USD Billion)

7.2.4 Market Size, By End-Use, 2021-2027 (USD Billion)

7.2.5 U.S.

7.2.5.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.2.5.2 Market Size, By Application, 2021-2027 (USD Billion)

7.2.5.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.2.6 Canada

7.2.6.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.2.6.2 Market Size, By Application, 2021-2027 (USD Billion)

7.2.6.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3 Europe

7.3.1 Market Size, By Country 2021-2027 (USD Billion)

7.3.2 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.3 Market Size, By Application, 2021-2027 (USD Billion)

7.3.4 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3.6 Germany

7.3.6.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.6.2 Market Size, By Application, 2021-2027 (USD Billion)

7.3.6.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3.7 UK

7.3.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.3.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3.8 France

7.3.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.3.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3.9 Italy

7.3.9.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.9.2 Market Size, By Application, 2021-2027 (USD Billion)

7.3.9.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3.10 Spain

7.3.10.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.10.2 Market Size, By Application, 2021-2027 (USD Billion)

7.3.10.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.3.11 Russia

7.3.11.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.3.11.2 Market Size, By Application, 2021-2027 (USD Billion)

7.3.11.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.4 Asia Pacific

7.4.1 Market Size, By Country 2021-2027 (USD Billion)

7.4.2 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.4.3 Market Size, By Application, 2021-2027 (USD Billion)

7.4.4 Market Size, By End-Use, 2021-2027 (USD Billion)

7.4.6 China

7.4.6.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.4.6.2 Market Size, By Application, 2021-2027 (USD Billion)

7.4.6.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.4.7 India

7.4.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.4.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.4.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.4.8 Japan

7.4.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.4.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.4.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.4.9 Australia

7.4.9.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.4.9.2 Market size, By Application, 2021-2027 (USD Billion)

7.4.9.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.4.10 South Korea

7.4.10.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.4.10.2 Market Size, By Application, 2021-2027 (USD Billion)

7.4.10.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.5 Latin America

7.5.1 Market Size, By Country 2021-2027 (USD Billion)

7.5.2 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.5.3 Market Size, By Application, 2021-2027 (USD Billion)

7.5.4 Market Size, By End-Use, 2021-2027 (USD Billion)

7.5.6 Brazil

7.5.6.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.5.6.2 Market Size, By Application, 2021-2027 (USD Billion)

7.5.6.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.5.7 Mexico

7.5.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.5.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.5.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.5.8 Argentina

7.5.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.5.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.5.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.6 MEA

7.6.1 Market Size, By Country 2021-2027 (USD Billion)

7.6.2 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.6.3 Market Size, By Application, 2021-2027 (USD Billion)

7.6.4 Market Size, By End-Use, 2021-2027 (USD Billion)

7.6.6 Saudi Arabia

7.6.6.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.6.6.2 Market Size, By Application, 2021-2027 (USD Billion)

7.6.6.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.6.7 UAE

7.6.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.6.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.6.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

7.6.8 South Africa

7.6.7.1 Market Size, By Animal Type, 2021-2027 (USD Billion)

7.6.7.2 Market Size, By Application, 2021-2027 (USD Billion)

7.6.7.3 Market Size, By End-Use, 2021-2027 (USD Billion)

Chapter 8 Company Landscape

8.1 Competitive Analysis, 2021

8.2 Boehringer Ingelheim International GmbH

8.2.1 Company Overview

8.2.2 Financial Analysis

8.2.3 Strategic Positioning

8.2.4 Info Graphic Analysis

8.3 Dechra Pharmaceuticals PLC

8.3.1 Company Overview

8.3.2 Financial Analysis

8.3.3 Strategic Positioning

8.3.4 Info Graphic Analysis

8.4 Elanco Animal Health Incorporated

8.4.1 Company Overview

8.4.2 Financial Analysis

8.4.3 Strategic Positioning

8.4.4 Info Graphic Analysis

8.5 Zoetis Inc.

8.5.1 Company Overview

8.5.2 Financial Analysis

8.5.3 Strategic Positioning

8.5.4 Info Graphic Analysis

8.6 Merck and Co Inc.

8.6.1 Company Overview

8.6.2 Financial Analysis

8.6.3 Strategic Positioning

8.6.4 Info Graphic Analysis

8.7 Assisi Animal Health

8.7.1 Company Overview

8.7.2 Financial Analysis

8.7.3 Strategic Positioning

8.7.4 Info Graphic Analysis

8.8 Other Companies

8.8.1 Company Overview

8.8.2 Financial Analysis

8.8.3 Strategic Positioning

8.8.4 Info Graphic Analysis

The Global Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market?

The global veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market size is projected to grow at a high CAGR value from 2022 and 2027.

Who are the major vendors in the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market?

Key and innovative vendors in the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market include Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Zoetis Inc., Merck and Co Inc., and Assisi Animal Health, among others.

Which region has the highest market share in the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market?

The North American region is estimated to hold the largest share of the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market.

What is the Covid-19 impact on future veterinary non-steroidal anti-inflammatory drugs (NSAIDs) manufacturers?

The COVID-19 pandemic has caused various issues restraining the growth of the non-steroidal anti-inflammatory drugs market. The increased focus on animal health owing to the pandemic has been positive for the market, while restrictions and lockdowns have seen pet owners postpone surgeries and other procedures which have decreased the demand for non-steroidal anti-inflammatory drugs. The market is expected to bounce back to pre-pandemic growth rates as postponed surgeries and procedures were carried out.

What are the major drivers in the veterinary non-steroidal anti-inflammatory drugs (NSAIDs) market?

The veterinary non-steroidal anti-inflammatory drugs market is largely driven by the growing demand for animal surgeries, increase adoption of pets, growing application of Veterinary Non-Steroidal Anti-Inflammatory Drugs for joint pain relief, and post-surgery pain relief, and the lack of animal behavioural modifications through its use.